Although homozygous deletion of MTAP is associated with increased PRMT5 inhibitor sensitivity in some pancreatic organoids, broader examination of the impact of MTAP status across different tumour cells lines suggests that it is not a reliable biomarker of sensitivity to PRMT5 inhibition [96,160,161]. Here, PRMT5 is linked to neoplasm.